New Technology– category –
-
RMIT Breakthrough: Magnetic Nanomaterials Remove Over 95% of Micro & Nanoplastics from Water in Just One Hour
RMIT Breakthrough! (Facebook) Australia Overview RMIT researchers have developed novel magnetic nanomaterials capable of removing over 95% of microplastics and nanoplastics from water within an hour. These nanomaterials bind effectively ... -
ACS Applied Nano Materials Unveils Pt/Mo2C Nanocatalyst Achieving Low Overpotentials of 47 mV in Acidic, 228 mV in Alkaline Media for Hydrogen Evolution Reaction
ACS Applied Nano Materials USA Overview Researchers have developed a Pt/Mo2C composite catalyst via cluster beam deposition, demonstrating exceptional performance in the hydrogen evolution reaction (HER). The optimized catalyst achieved ... -
Upstate Cancer Center Engineers Magnetically-Guided Nanoparticles for Targeted Chemotherapy, Achieving Tumor Shrinkage with Minimal Side Effects
Upstate Cancer Center (Facebook) USA Overview Researchers at Upstate Cancer Center have developed magnetically-guided nanoparticles (10-100 nm) for targeted chemotherapy, demonstrating tumor shrinkage while significantly reducing systemi... -
Protein Interactions Shed New Light on Autism Causes: Advancing Neurological Disease Understanding
Fierce Biotech USA Overview Research reports that complex protein-protein interactions offer new insights into the fundamental causes of autism spectrum disorder (ASD). This discovery is a critical step towards understanding the intricat... -
European Commission Approves Acadia’s Trofinetide as First EU Rett Syndrome Treatment
European Pharmaceutical Review EU Overview The European Commission (EC) has approved Acadia Pharmaceuticals' trofinetide as the first treatment for Rett syndrome in the European Union. This approval represents a landmark advancement, off... -
FDA Approves First Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa), Offering New Option for Patients Aged 8+
Pharmacy Times USA Overview The U.S. FDA has approved the first gene therapy for Glycogen Storage Disease Type Ia (GSDIa), targeting the underlying cause of this rare metabolic disorder in patients aged 8 and older. GSDIa results from a ... -
Decoding Hashimoto’s: Exosomes Emerge as Pivotal for Diagnosis and Therapy
PubMed International Overview A groundbreaking study reveals the critical role of exosomes in the pathogenesis of Hashimoto's thyroiditis, positioning them as promising new diagnostic biomarkers and therapeutic targets. The research deta... -
Broad Institute Achieves Long-Term Brain Organoid Longevity and Streamlines Prime Editing with AI
Broad Institute USA Overview The Broad Institute announced a significant milestone on August 20, 2026, where an AI model streamlined the prime editing process and enabled the long-term longevity of brain organoids. The institute actively... -
AI-Driven ‘GRACE’ System Poised to Revolutionize 3D Bioprinting, Address Organ Shortages; Market Expected to Hit $6.7B by 2033
TELUGU TIMES International Overview A new AI-driven system, 'GRACE,' set for unveiling in September 2025, promises to revolutionize 3D bioprinting by designing optimal vascular networks, significantly reducing cell death in bioprinted ti... -
Mayo Clinic Leads ARPA-H Initiative to Advance Gene-Editing Therapies for Rare Immune Diseases, Integrating CRISPR and Novel Delivery for Over 500 Inborn Errors of Immunity
Mayo Clinic News Network USA Overview Mayo Clinic is participating in a 5-year collaborative research initiative, funded by an ARPA-H grant, to accelerate the development of gene-editing therapies for rare immune diseases. This initiativ...
